Clinical Review Regular review

Managing testicular cancer

BMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7302.1583 (Published 30 June 2001) Cite this as: BMJ 2001;322:1583
  1. DP Dearnaley, head of urology (davidd@icr.ac.uk),
  2. RA Huddart, senior lecturer,
  3. A Horwich, professor
  1. Academic Unit of Clinical Oncology, Royal Marsden NHS Trust, Sutton SM2 5PT
  1. Correspondence to: DP Dearnaley

    Germ cell tumours of the testis are the commonest malignancy in men aged 20–40 years. Considerable therapeutic improvements in management—based on the cancer's responsiveness to chemotherapy that contains platinummean that over 95% of these patients can now expect to be cured.

    Summary points

    Testicular cancer is the most common cancer in younger men

    The incidence has been increasing by 15-20% in successive five year periods

    Clinical trials organised by the UK's Medical Research Council and other international groups have defined modern clinical practice

    Cure rates of >95% can be achieved

    Advanced and recurrent cancers should be treated by multidisciplinary teams in specialist centres

    Methods

    Much of the clinical management discussed in this review is based on the guidelines of the UK's Clinical Oncology Information Network, which were developed with the Scottish Intercollegiate Guidelines Network.1 These were based on a systematic review of clinical data including prospective phase III randomised trials performed internationally. The sections that discuss causes, follow up, and future developments reflect our research interests and personal experience.

    Incidence and aetiology

    Testicular germ cell tumours

    Testicular germ cell tumours are uncommon cancers; they account for around 1% of all cancers in males. About 1400 new cases are diagnosed in the United Kingdom each year. Germ cell tumours have a unique epidemiological profile for a solid tumour. Their peak incidence occurs among men aged 25–35 years, and there is a distinctive geographical and racial variation. The highest incidence is among white men in northern Europe.

    These factors suggest that both genetic and environmental factors are important in the development of testicular germ cell tumours. The age distribution at onset suggests that an initiating event occurs prenatally and that the tumour develops from adolescence. The overall incidence of testicular germ cell tumours has been steadily rising throughout the 20th century, with an increase of 15-20% being seen in …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe